Cargando…
In vitro dexamethasone treatment does not induce alternative ATM transcripts in cells from Ataxia–Telangiectasia patients
Short term treatment with low doses of glucocorticoid analogues has been shown to ameliorate neurological symptoms in Ataxia–Telangiectasia (A–T), a rare autosomal recessive multisystem disease that mainly affects the cerebellum, immune system, and lungs. Molecular mechanisms underlying this clinica...
Autores principales: | Pozzi, Elisa, Giorgio, Elisa, Mancini, Cecilia, Lo Buono, Nicola, Augeri, Stefania, Ferrero, Marta, Di Gregorio, Eleonora, Riberi, Evelise, Vinciguerra, Maria, Nanetti, Lorenzo, Bianchi, Federico Tommaso, Sassi, Maria Paola, Costanzo, Vincenzo, Mariotti, Caterina, Funaro, Ada, Cavalieri, Simona, Brusco, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677391/ https://www.ncbi.nlm.nih.gov/pubmed/33214630 http://dx.doi.org/10.1038/s41598-020-77352-z |
Ejemplares similares
-
Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
por: Leuzzi, Vincenzo, et al.
Publicado: (2015) -
ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer
por: Putti, Sabrina, et al.
Publicado: (2021) -
Identification of ATM Mutations in Korean Siblings with Ataxia-Telangiectasia
por: Huh, Hee Jae, et al.
Publicado: (2013) -
Ataxia-Telangiectasia with Novel Splicing Mutations in the ATM Gene
por: Jeong, Heejeong, et al.
Publicado: (2014) -
Atm reactivation reverses ataxia telangiectasia phenotypes in vivo
por: Di Siena, Sara, et al.
Publicado: (2018)